NNC 0151-0000-0000

N/A

Report date: 2024/09/06 20:00:43

Base Information

Drug NameNNC 0151-0000-0000

Drug Alias NameAnti-C5aR-151NNC 0151-0000-0000NNC 0151NN-8209

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-C5AR1

TargetsC5a anaphylatoxin chemotactic receptor 1

Therapy Area/IndicationsInflammationArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaPolandRomania +[6]

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsInflammationArthritis, Rheumatoid

ATC CodeN/A